All metastatic tumors with amplified MYCN genes are aggressive, whereas metastatic tumors with non amplified MYCN genes have variable clinical behaviors influenced by the patient's age at diagnosis [50]. This evidence concerns the gene MYCN and metastatic neoplasm.